MedTrace Logo

Hemoglobin and Iron Recovery Study

NCT01555060 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2014-01-23

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors (\<60 years old vs. at least 60 years old) and in donors with replete vs. diminished pre-donation iron stores.

Conditions

  • Recovery of Hemoglobin and Iron Stores After Blood Donation

Interventions

DIETARY_SUPPLEMENT

ferrous gluconate

daily capsule of ferrous gluconate containing 38 mg of elemental iron

Sponsors & Collaborators

  • Institute for Transfusion Medicine

    collaborator UNKNOWN

  • Versiti

    collaborator OTHER

  • Blood Centers of the Pacific

    collaborator UNKNOWN

  • American National Red Cross

    collaborator OTHER

  • University of California, San Francisco

    collaborator OTHER

  • Vitalant Research Institute

    collaborator OTHER

  • RTI International

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Joe Kiss, MD · Institute for Transfusion Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01555060 on ClinicalTrials.gov